Frost & Sullivan Recognizes Exiqon A/S for Growth Strategy Leadership in the Cancer Molecular Diagnostics Market

PALO ALTO, Calif.--(BUSINESS WIRE)--Based on its recent analysis of the U.S. cancer molecular diagnostics market, Frost & Sullivan recognizes Exiqon A/S with the 2008 North American Frost & Sullivan Award for Growth Strategy Leadership. The award commends Exiqon for a well-executed market entry strategy, continued focus on innovation, key partnerships with industry and Cancer Research Centers, and market-driven product development approach – all of which position the company as a formidable force in its industry.

MORE ON THIS TOPIC